Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine

Menstrual Migraine (MM) Headaches Clinical Trial

Official title: Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment)Of Menstrual Migraine

Status Completed

Clinical Trial Summary

Females 18 years of age or older with at least one year history of menstrual migraine (MM) headaches participated in a Phase 4 clinical trial to evaluate the efficacy of frovatriptan when used at the early stage (International Headache Society [IHS] Grade 1) of MM compared with patients' current treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Menstrual Migraine (MM) Headaches
• Migraine Disorders

• NCT number: NCT00904098
• Study type: Interventional
• Source: Endo Pharmaceuticals
• Status: Completed
• Phase: Phase 4
• Start date: September 2005
• Completion date: February 2006